Precision, Profit, and Patient Care: The Orthopedic Opportunity for Ambulatory Surgery Centers

Updated on July 24, 2026

Ambulatory Surgery Centers (ASCs) have become a defining feature of the modern healthcare landscape, reshaping how outpatient care is delivered across the United States. With more than 10,000 facilities in operation, these centers now perform millions of procedures each year across a growing range of specialties.

For patients, the value proposition is clear. ASCs offer shorter recovery times, lower out-of-pocket costs, and a more convenient care experience. For providers, they create an opportunity to deliver high-quality care in a more controlled, efficient environment.

This growth reflects a broader shift toward value-based care. Advances in surgical techniques, technology, and minimally invasive approaches have expanded what can safely be done outside the hospital. Orthopedics has emerged as one of the most significant areas of opportunity as Medicare policy increasingly encourages appropriate joint replacement procedures to move from inpatient hospitals into outpatient and ambulatory surgery center environments. Recent MedPAC reporting shows that total hip, knee, and shoulder replacements are among the higher-acuity procedures gaining traction in ASCs.

Mounting Pressures in a Competitive Environment

However, despite their advantages, ASCs are no longer operating with the same structural tailwinds that once defined the model. Rising operational costs, persistent staffing challenges, and inflationary pressures are tightening margins across the board.

At the same time, due to their ability to support more complex cases, hospitals are aggressively expanding their outpatient capabilities, competing directly for both patients and surgeon partnerships. Reimbursement dynamics are also shifting, with payer contracts becoming more complex and rates less predictable.

Surgeon behavior adds another layer of complexity. Many physicians now operate across multiple facilities, directing case volume based on efficiency, technology access, and financial alignment. For ASCs, this means that growth is no longer guaranteed by convenience alone.

In this environment, scale without strategy is no longer enough. Sustained success depends on how effectively centers adapt while preserving the core efficiencies that made them successful in the first place.

Procedure Optimization: Focusing on High-Value Growth

One of the most direct ways ASCs can strengthen both clinical and financial performance is by prioritizing high-value procedures.  Total joint replacements have become a leading example of high-value outpatient care, with ASC case volumes increasing more than 300% in recent years and studies showing lower readmission and complication rates compared with inpatient settings for appropriately selected patients.

As more of these procedures shift to the outpatient setting, ASCs that align their care pathways, patient selection criteria, and surgical workflows around these cases are better positioned to capture sustainable growth.

This is not simply about increasing volume. It is about ensuring that each case contributes meaningfully to both margin and quality, reinforcing the broader value proposition of the ASC model.

Operational Efficiency: Strengthening the Core

While procedure mix drives revenue, operational performance determines whether that revenue translates into profitability. Lean management principles remain foundational, enabling ASCs to streamline workflows, reduce turnover times, and maximize the productivity of limited staff resources.

Cross-training staff plays a critical role in this effort, creating flexibility across teams and reducing dependency on highly specialized roles. This adaptability becomes especially important in an environment where staffing remains a persistent challenge.

Supply chain management is another key lever. Strategic sourcing through group purchasing organizations, combined with improved inventory visibility, allows ASCs to control costs without compromising care quality. Over time, incremental gains in scheduling, staffing, and supply utilization compound into meaningful improvements in overall performance.

Technology Integration: Driving Precision and Differentiation

As operational efficiency becomes table stakes, technology is increasingly where ASCs differentiate themselves.

In orthopedics, advancements in surgical technology are transforming both precision and accessibility. Robotic-assisted systems continue to improve accuracy and consistency, while newer, open-platform, handheld navigation technologies are redefining what is feasible in an outpatient setting.

These systems provide real-time data on implant alignment and limb positioning, helping surgeons achieve more precise outcomes without the need for large capital investments or additional pre-operative imaging. For ASCs, this represents a meaningful shift. Advanced capabilities are no longer limited by infrastructure, room size, or physician preference constraints.

At the same time, solutions designed with minimal instrument requirements and single-use components help reduce sterilization demands, shorten turnover times, and simplify staffing needs. This alignment between clinical performance and operational efficiency is what makes certain technologies true growth enablers rather than just an added expense.

Flexibility as a Strategic, Staffing, and Competitive Advantage

Beyond individual technologies, the broader approach to technology adoption is becoming just as important. Open platform models, which allow ASCs to work across multiple systems and vendors, are emerging as a strategic advantage. In addition, an open-platform model puts the power back into the hands of facilities, which increases their negotiation leverage. 

This flexibility and autonomy supports surgeon recruitment and retention by accommodating a range of clinical preferences. Rather than forcing alignment to a single system, ASCs can create an environment that appeals to diverse surgical approaches.

Operationally, this also enables greater efficiency. Staff can be trained across multiple workflows, reducing bottlenecks, and creating a more adaptable, scalable, and competitive work environment for ambulatory organizations. In a landscape where both surgeons and staff have increasing choice, this flexibility can be a decisive factor.

The Future of Orthopedics in ASCs

The shift toward outpatient orthopedic care is expected to accelerate, with projections indicating that more than half of joint replacement procedures could be performed in ASCs by 2030.

This transition signals a broader redefinition of where and how high-value care is delivered. For ASCs, the opportunity is significant, but so is the responsibility to ensure that growth is supported by the right infrastructure, processes, and technology.

Aligning Profitability with Patient Outcomes

The next phase of ASC growth will not be defined by expansion alone, but by how effectively centers evolve. Profitability and patient outcomes are no longer competing priorities. They are increasingly the result of the same strategic decisions.

ASCs that focus on optimizing procedure mix, strengthening operational performance, and investing in scalable, precision-driven technology will be best positioned to succeed. These centers will not only maintain financial stability in a more complex environment, but also help define the future of outpatient surgical care.

In that future, precision, profitability, and patient experience are not tradeoffs. They are the standard.

Nicolas Aldrich Headshot
Nicolas Aldrich
Vice President at OrthAlign |  + posts

Nic Aldrich has over 10 years of experience in the medical device industry. Most recently, he managed a global marketing team at Stryker, focused on revision knee, hip and limb salvage implants, and was involved in several key 3D printed product launches in the primary and revision knee space. Prior to joining Stryker, Nic was part of the marketing team at Ansell Healthcare, where he focused on strategic planning and mergers and acquisitions. Prior to Ansell, Nic worked in finance for two Johnson & Johnson companies: Cordis Corp, a cardiovascular/endovascular company, and Ethicon Inc, a suture and surgical technologies business. Nic has a proven track record of developing strategies and driving efficient and effective marketing campaigns that deliver results.